Epidemiology of fungaemia in a paediatric hospital of high complexity;Epidemiología de las fungemias en un hospital pediátrico de alta complejidad

Revista Iberoamericana de Micologia

Volumn 27, Issue 4, 2010, Pages 200-202

  Santos, Patricia Ester ^a   Córdoba, Susana ^b   Carrillo Muñoz, Alfonso ^c   Rodero, Laura ^b   Rubeglio, Etelvina ^a   Soria, Marcelo ^d  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d ACIAM   (Spain)

Author keywords

Antifungal susceptibility; Argentina; Candida; Epidemiology; Fungaemia

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; ARGENTINA; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; FUNGEMIA; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; SPECIES COMPARISON; SPECIES DISTRIBUTION; YEAST;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGEMIA; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 78649909196     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.riam.2010.07.002     Document Type: Article

References (24)

1. Agresti A. Categorical data analysis. Wiley series in Probability and Statistics 2002, Wiley, Wiley-Interscience, New York. Second Edition.
2. Ashkenazi S., Leibovici L., Samra Z., Konisberger H., Drucker M. Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 1992, 14:949-951.
3. Beck-Sagué C.M., Jarwis W.R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993, 167:1247-1251. The National Nosocomial Infections Surveillance System.
4. Berrouane Y.F., Herwaldt A., Pfaller M.A. Trends in antifungal use and Epidemiology of nosocomial yeast infections in an university hospital. J Clin Microbiol 1999, 37:531-537.
5. Blyth C.C., Chen S.C., Slavin M.A., Serena C., Nguyen Q., Marriott D., et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009, 123:1360-1368. the Australian Candidemia Study.
6. Cantón E., Pemán J. Curvas de letalidad en antifúngicos. Rev Iberoam Micol 1999, 16:82-85.
7. Del Palacio A., Villar J., Alhambra A. Epidemiología de la candidiasis invasiva en población pediátrica y adulta. Rev Iberoam Micol 2009, 26:2-7.
8. Edmond M.B., Wallace S.E., Mc Clish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in United States Hospitals; a three year analysis. Clin Infect Dis 1999, 29:239-244.
9. Ewards J.E. Candida species. Principles and Practice of Infectious Diseases 1995, 2289-2306. Churchill Livingstone, New York. 4th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
10. Fraser V.J., Jones M., Dunkel J., Storfer S., Medoff G., Dunagan W.C. Candidemia in a tertiary care hospital: Epidemiology, Risk factors and Predictors of Mortality. Clin Infect Dis 1992, 15:414-421.
11. Horn D.L., Neofytos D., Anaissie E.J., Fishman J.A., Steinbach W.J., Olyaei A.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703.
12. Klepser M.E., Ernst E.J., Lewis R.E., Ernst M.E., Pfaller M. Influence of test conditions on antifungal time-kill curve results: Propose for standardized methods. Antimicrob Agents Chemother 1998, 42:1207-1212.
13. Kurtzman, Fell N.J.W. The yeast, a taxonomic study 1998, Ed. Elsiever Science Publisher B.W., Amsterdam.
14. Lewis R.E. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 2009, 25:1732-1740.
15. Nace H.L., Horn D., Neofytos D. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007. Diagn Microbiol Infect Dis 2009, 64:289-294.
16. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A2. National Committee for Clinical Laboratory Standards 2002, National Committee for Clinical Laboratory Standards, Wayne, PA, USA.
17. Orozco P.A., Cortés J.A., Parra C.M. Colonización por levaduras en recién nacidos y personal de salud en la unidad de cuidados intensivos neonatales de un hospital universitario en Bogotá, Colombia. Rev Iberoam Micol 2009, 26:108-111.
18. Pontón J., Rüchel R., Clemons K.V., Coleman D.C., Grillot R., Guarro J., et al. Emerging pathogens. Med Mycol 2000, 38(Suppl 1):225-236.
19. R Development CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Viena, Austria 2007. ISBN 3-900051-07-0. Disponible en: http://www.R-project.org.
20. Résendiz Sanchez J., Morales Aguirre J.J. Factores asociados a mortalidad por fungemias causadas por Candida sp. en niños. Bol Med Hosp Infant Mex 2007, 64:91-98.
21. Roilides E., Kadiltsoglou I., Zahides D., Bibashi E. Invasive candidosis in pediatric patients. Clin Microbiol Infect 1997, 3:192-197.
22. Ruan S.Y., Hsueh P.R. Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 2009, 108:443-451.
23. Silva A.P., Miranda I.M., Lisboa C., Pina-Vaz C., Rodrigues A.G. Prevalence, Distribution and antifungal susceptibility profile of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in a tertiary care hospital. J Clin Microbiol 2009, 47:2392-2397.
24. Vandijck D.M., Blot S.I., Vandekerckhove L., Vogelaers D.P. Fluconazole exposure and selection for Candida non-albicans. Anesth Analg 2008, 107:2091.